Advertisement

Who should not take Claritin-D?

Claritin-D (12-hour or 24-hour) should not be taken by people with kidney disease, high blood pressure, diabetes, glaucoma, enlarged prostate, thyroid problems, urination problems or heart disease, without first discussing it with your doctor. Do not use this medication without letting your doctor know that you use an MAOI (monoamine oxidase inhibitor), since the combination can have life-threatening results. People with following medical conditions should not use Claritin-D:

  • hypertension
  • diabetes mellitus
  • ischemic heart disease
  • increased intraocular pressure
  • hyperthyroidism
  • renal impairment
  • prostatic hypertrophy

Central nervous system stimulation with convulsions or cardiovascular failure may occur. Children under two years of age should not be given this medication.

Continue Learning about Respiratory Agent

Will my child need oxygen therapy for the rest of his life?
Stacy Wiegman, PharmDStacy Wiegman, PharmD
How long your child needs oxygen therapy depends on why he needs oxygen therapy. If your child h...
More Answers
Does roflumilast have any side effects?
Donna Hill Howes, RNDonna Hill Howes, RN
Side effects from roflumilast may include dizziness, headache, weight loss, loss of appetite, nausea...
More Answers
How do I keep my child safe while using oxygen therapy?
Stacy Wiegman, PharmDStacy Wiegman, PharmD
Do not smoke, and keep the oxygen away from any open flame or heat. Also, secure oxygen carts in...
More Answers
What should I know before taking a 5-alpha reductase inhibitor?
Donna Hill Howes, RNDonna Hill Howes, RN
If you have impaired liver function, a 5-alpha reductase inhibitor may not be a good option for you....
More Answers

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.